Literature DB >> 6407852

Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent.

U B Olsen, E Arrigoni-Martelli.   

Abstract

In pentobarbital sodium-anaesthetized dogs, pinacidil was infused for approximately 5 min into the carotid, coronary, femoral or renal artery at a rate of 10 micrograms/kg per min. The infusion, which did not affect systemic blood pressure, rapidly and markedly increased blood flow to any of the regions studied. When given i.v., 0.2 mg/kg pinacidil caused a moderate reduction in mean arterial blood pressure (15-20 mmHg) associated with an increase in coronary and renal blood flow while femoral and carotid blood flow remained unchanged; 0.5 mg/kg led to a marked (40-60 mmHg) reduction in blood pressure associated with an increase in coronary blood flow whereas renal, carotid and femoral blood flow stabilized at control levels. Indomethacin (2.5 mg/kg i.v.) failed to reverse the hypotension induced by pinacidil. The results are in accord with the concept that the vascular effect of pinacidil is due to direct smooth muscle relaxation which does not depend on prostaglandin synthesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407852     DOI: 10.1016/0014-2999(83)90591-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 2.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 3.  Pinacidil. Preclinical investigations.

Authors:  I Ahnfelt-Rønne
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers.

Authors:  P Girard; J L Saumet; F Dubois; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.

Authors:  J S Southerton; A H Weston; K M Bray; D T Newgreen; S G Taylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

6.  Hypotensive and peripheral vascular effects in healthy volunteers of repeated oral administration of pinacidil.

Authors:  J L Saumet; F Dubois; P Girard; A Geloen; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Acute haemodynamic effects of pinacidil in man.

Authors:  D P Nicholls; J G Murtagh; M E Scott; P Morton; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

8.  Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.

Authors:  C B Nielsen; E B Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  In vitro studies on the mode of action of pinacidil.

Authors:  A H Weston; K M Bray; S Duty; A D McHarg; D T Newgreen; J S Southerton
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Long-term effects of pinacidil in hypertensive dialysis patients.

Authors:  E G Breen; D Mulhall; J A Keogh
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.